<analysis>
**Action 1 (identity-based credential control).** The security/IAM team has strong incentive after 14 October to treat this as a hardening fix rather than a policy fight, and it removes the allowlist objection. The replay and the 30-minute paging are easy.

Real obstacles:
- Retrofitting per-campaign workload identity across CI-6 infrastructure in one month is substantial engineering.
- Research infrastructure commonly relies on shared service tokens and cached configs, so the replay will likely show many legitimate "foreign token" uses. That makes immediate blocking a run-interruption risk.
- Research leads will push for shadow mode first.

The most likely good outcome is enforcement on a subset, or shadow-mode-then-enforce. Success means an *enforced* control covering internal scope adopted as the external-deployment precondition. P(failure) 45%.

**Action 2 (alignment evidence into the deployment decision).** The proxy ablation is 40% complete on preemptible compute, so finishing it is plausible but not certain. The 100 blind-written items are feasible. The 35 AISI items depend on AISI's track record of slipping. The honeypot audit needs post-training and RSP sign-off and an AISI item-holding arrangement, which is unlikely to be *standing* within a month. Listing counsel may restrict what goes to AISI beyond the confidential notice.

Success criterion: the paired-eval result and incident formally in the report-before-deploy package, and the audit at least approved for pilot. These components are roughly 0.75 × 0.7 × 0.55. P(failure) 50%.

**Action 3 (measurement).** Components and rough odds:
- OpenAI account accepted and the rerun published: about 0.7. The terms may include a pre-publication window.
- Google observer preview yielding a publishable Gemini Agent Mode run: about 0.5.
- The Grok entry and the charter draft are trivial.

The primary aim needs both the OpenAI and Gemini results, about 0.35 jointly, though a partial with OpenAI only is likely. P(failure) 55%.

**Action 4 (defence).** This runs through routine, proven channels. Vendor B's patch could slip, and verification depends on it (about 0.75). P(failure) 25%.

**Action 5 (policy).** The human-signed letter is very likely. However, the player's stated outcome, "CAISI's increase survives," hinges on conference, and a second CR or full-year flat funding is the base-rate outcome in late November. The attributed position stays held while listing is pending. Hawley's staff may accept data, but no hearing has been noticed. The primary aim is unlikely. P(failure) 60%.

**Action 6 (benefits).** The three-arm test launched mid-to-late October, so its interim completion data will be thin. Product will likely refuse to scale on it, and Legal will review publication. The cap has risen in 2.5k increments, so 30k is unlikely; 27.5k is plausible. Placement wages need the state data agreements. The Cellwise target of 45% or more is about a coin flip. ANT-17 is routine. Many components are each partial. P(failure) 50%.

**Standing threats and sub-risks I am declaring:**
- CI-6 internal anomaly recurring (scope or credential misuse, any tier): 50%. Non-benign tier: 25%.
- Leak or press report of the 14 October incident before the quarterly report: 20%.
- Grok Agents misused in a documented fraud or intrusion attributed publicly: 40%.
- Grok 6 reaction: a congressional letter to xAI (35%), a CAISI public statement (30%), enterprise customer pauses (20%).
- Successful election-office intrusion on 4 November: 8%.
- DeepSeek V6 weights released this month: 35%.
- An unhardened-sector AI-lure fraud of $500k or more: 55%.
</analysis>

<action_odds>
Action 1 [Identity-based credential control]: P(failure) 45%. Reason: Security has strong post-incident motivation and no allowlist is needed. But retrofitting workload identity in a month is heavy, the replay will likely surface many legitimate shared-token uses, and research leads will push shadow mode. Success requires an enforced internal-scope control adopted as the deployment precondition.

Action 2 [CI-6 evidence into deployment decision]: P(failure) 50%. Reason: The ablation and new items are feasible. AISI item delivery keeps slipping, the honeypot audit needs post-training, RSP and AISI buy-in to become standing, and listing counsel may restrict the package. Several mid-probability components combine.

Action 3 [Measurement follows leaders]: P(failure) 55%. Reason: The primary aim needs both the OpenAI test-account rerun (~0.7) and a publishable Gemini Agent Mode run via the observer preview (~0.5), about 0.35 jointly. The Grok entry and charter draft are trivial and do not carry the action.

Action 4 [Defence for forcing events]: P(failure) 25%. Reason: These are routine, proven channels with consistent past success. The main risk is vendor B's patch slipping past 18 November, which would leave verification incomplete.

Action 5 [Policy via human-signed channels]: P(failure) 60%. Reason: The letter is near-certain, but the stated outcome (CAISI's +3% surviving conference) is mostly exogenous. Another CR or a flat outcome is the base rate. The attributed position remains held pre-listing, and no hearing has been noticed.

Action 6 [Visible benefits at scale]: P(failure) 50%. Reason: Interim three-arm data is too young to justify scaling, the cap historically moves by 2.5k rather than to 30k, wage fields depend on unsigned state agreements, and the Cellwise ≥45% target is about a coin flip. Partial gains are likely; the full outcome is not.
</action_odds>
